期刊文献+

以百白破疫苗为基础的联合疫苗研究进展和展望 被引量:11

原文传递
导出
摘要 百日咳、白喉和破伤风联合疫苗(DTP)作为最早纳入WHO扩大免疫规划(EPI)的疫苗,已经在预防和控制这3种传染病方面发挥了重要作用。20世纪70年代,由于接种灭活全细胞百白破疫苗(DTwP)后出现了严重的不良反应,
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2012年第9期853-856,共4页 Chinese Journal of Preventive Medicine
  • 相关文献

参考文献23

  • 1de Melker HE, Schellekens JF, Neppelenbroek SE, et al. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis,2000, 6(4) : 348-357.
  • 2骆鹏,张庶民.百日咳免疫控制研究进展[J].中国公共卫生,2010,26(5):651-653. 被引量:25
  • 3StanleyAP.WalterAO.疫苗学.梁晓峰,罗凤基,封多佳,译.5版.北京:人民卫生出版社,2011:1193-1195.
  • 4Decker MD, Edwards KM, Bradley R, et al. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr, 1992, 120(2 Pt 1 ):184-189.
  • 5Shinefield H, Black S, Thear M, et al. 3atety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus- acellular pertussis vaccines. Pediatr Infect Dis J, 2006, 25 (4) : 287-292.
  • 6Mawas F, Dickinson R, Douglas-Bardsley A, et al. Immune interaction between components of acellular pertussis-diphtheria- tetanus (DTaP) vaccine and haemophilus influenzae b (Hib) conjugate vaccine in a rat model. Vaccine, 2006, 24 ( 17 ) : 3505-3512.
  • 7Eskola J, Ward J, Dagan R, et al. Combined vaccination of haemophilus influenzae type b conjugate and diphtheria-tetanus- pertussis containing acellular pertussis. Lancet, 1999, 354 ( 9195 ) :2063-2068.
  • 8Carlsson RM, Claesson BA, Fagerlund E, et al. Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy. Pediatr Infect Dis J, 2002, 21 (6) :535-541.
  • 9Li RC, Li FX, Li YP, et al. Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China. Vaccine, 2011, 29 (10) : 1913-1920.
  • 10Li RC, Li FX, Li YP, et al. Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP ~ T vaccine compared to separate vaccines ( DTaP, PRP - T and IPV) following primary vaccination of healthy infants in the People' s Republic of China. Vaccine, 2011, 29(50) :9337-9344.

二级参考文献16

共引文献32

同被引文献81

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部